Compare GRNQ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRNQ | CRIS |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5M | 20.6M |
| IPO Year | 2014 | 2000 |
| Metric | GRNQ | CRIS |
|---|---|---|
| Price | $1.78 | $0.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 11.1K | ★ 212.3K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | $3,673,997.00 | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 24.55 | ★ 31.50 |
| 52 Week Low | $1.10 | $0.46 |
| 52 Week High | $3.18 | $3.13 |
| Indicator | GRNQ | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 43.94 |
| Support Level | $1.63 | $0.48 |
| Resistance Level | $1.88 | $0.63 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 76.47 | 44.18 |
Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.